Best-in-Class

Type: Book

As of November 2026, Best-in-Class has been mentioned in one podcast episode on The Money Mondays Podcast (Aug 2025). Gary Lipsky cites it as his best-selling book focused on asset management, positioned as education for investors/operators.

A first-in-class medication is a prototype drug that uses a "new and unique mechanism of action" to treat a particular medical condition. While the Food and Drug Administration's Center for Drug Evaluation and Research tracks first-in-class medications and reports on them annually, first-in-class is not considered a regulatory category. Although many first-in-class medications qualify as breakthrough therapies, Regenerative Medicine Advanced Therapies and/or orphan drugs, first-in-class status